While Pfizer’s corporate flight department suffered a drop-off in flights during the pandemic, it was able to demonstrate the critical role it plays in the company and has been credited with helping to reduce by two weeks the time it took to bring the Pfizer vaccine to market, said v-p of corporate aviation John Witzig. Participating in the Flight Safety Foundation/NBAA Business Aviation Safety Seminar's opening general session on Tuesday, Witzig detailed how the pandemic had shuttered his operations and the steps his department took not only to get up and running but to step up as the company was conducting trials for its Covid-19 vaccine.
"As slow as our flying was for last year, the reality is that the value the flight department generated for the business probably exceeded the value of every trip we’ve ever done,” he said. When the pandemic first set in, Witzig said the reaction was that they were going to be down just a short while. But as time went on, the concern became about maintaining proficiency and currency.
More In Safety
